02.08.2011 • NewsLuke KissamAlbemarlePeople

Luke Kissam Elected CEO of Albemarle

Luke C. Kissam will take over as Albemarles CEO on Sept.1.
Luke C. Kissam will take over as Albemarle's CEO on Sept.1.

Albemarle has promoted Luke C. Kissam to CEO, effective Sept.1. Kissam joined Albemarle in September 2003 as vice president, general counsel and corporate secretary and served as senior vice president, manufacturing and law, and corporate secretary from January 2008 until his promotion to president in March 2010.

Prior to joining Albemarle, Kissam served as vice president, general counsel and secretary of Merisant, having previously served as associate general counsel of Monsanto.

Current CEO Mark C. Rohr will continue as executive chairman of the Albemarle Board of directors.   

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read